Laurent Martiny

Prof. Dr. Laurent Martiny

orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 March 2017 in Molecules
Verified
Journal Article
Open access
PDF file
LNLaetitia Nivelle
Laetitia Nivelle
LMLaurent Martiny
Laurent Martiny
Eric CourotEric Courot
Eric Courot
Philippe JeandetPhilippe Jeandet
Philippe Jeandet
Aziz AzizAziz Aziz
Aziz Aziz
Dominique DelmasDominique Delmas
Dominique Delmas
In the present study, resveratrol and various oligomeric derivatives were obtained from a 14 L bioreactor culture of elicited grapevine cell suspensions (Vitis labrusca L.). The crude ethyl acetate stilbene extract obtained from the culture medium was fractionated by centrifugal partition chromatography (CPC) using a gradient elution method and the major stilbenes contained in the fractions were subsequently identified by using a 13C-NMR-based dereplication procedure and further 2D NMR analyses including HSQC, HMBC, and COSY. Beside δ-viniferin (2), leachianol F (4) and G (4′), four stilbenes (resveratrol (1), ε-viniferin (5), pallidol (3) and a newly characterized dimer (6)) were recovered as pure compounds in sufficient amounts to allow assessment of their biological activity on the cell growth of three different cell lines, including two human skin malignant melanoma cancer cell lines (HT-144 and SKMEL-28) and a healthy human dermal fibroblast HDF line. Among the dimers obtained in this study, the newly characterized resveratrol dimer (6) has never been described in nature and its biological potential was evaluated here for the first time. ε-viniferin as well as dimer (6) showed IC50 values on the three tested cell lines lower than the ones exerted by resveratrol and pallidol. However, activities of the first two compounds were significantly decreased in the presence of fetal bovine serum although that of resveratrol and pallidol was not. The differential tumor activity exerted by resveratrol on healthy and cancer lines was also discussed.

9 November 2017 in Molecules
Verified
Journal Article
Open access
PDF file
LNLaetitia Nivelle
Laetitia Nivelle
JHJane Hubert
Jane Hubert
Eric CourotEric Courot
Eric Courot
NBNicolas Borie
Nicolas Borie
JRJean-Hugues Renault
Jean-Hugues Renault
MTMichel Tarpin
Michel Tarpin
A new resveratrol dimer (1) called labruscol, has been purified by centrifugal partition chromatography of a crude ethyl acetate stilbene extract obtained from elicited grapevine cell suspensions of Vitis labrusca L. cultured in a 14-liter stirred bioreactor. One dimensional (1D) and two dimensional (2D) nuclear magnetic resonance (NMR) analyses including 1H, 13C, heteronuclear single-quantum correlation (HSQC), heteronuclear multiple bond correlation (HMBC), and correlation spectroscopy (COSY) as well as high-resolution electrospray ionisation mass spectrometry (HR-ESI-MS) were used to characterize this compound and to unambiguously identify it as a new stilbene dimer, though its relative stereochemistry remained unsolved. Labruscol was recovered as a pure compound (>93%) in sufficient amounts (41 mg) to allow assessment of its biological activity (cell viability, cell invasion and apoptotic activity) on two different cell lines, including one human skin melanoma cancer cell line HT-144 and a healthy human dermal fibroblast (HDF) line. This compound induced almost 100% of cell viability inhibition in the cancer line at a dose of 100 μM within 72 h of treatment. However, at all tested concentrations and treatment times, resveratrol displayed an inhibition of the cancer line viability higher than that of labruscol in the presence of fetal bovine serum. Both compounds also showed differential activities on healthy and cancer cell lines. Finally, labruscol at a concentration of 1.2 μM was shown to reduce cell invasion by 40%, although no similar activity was observed with resveratrol. The cytotoxic activity of this newly-identified dimer is discussed.

19 May 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
CLClaudia Herrera Leon
Claudia Herrera Leon
FRFrancisco Ramos-Martin
Francisco Ramos-Martin
HBHassan EL BTAOURI
Hassan EL BTAOURI
VAViviane Silva Pires Antonietti
Viviane Silva Pires Antonietti
Pascal SonnetPascal Sonnet
Pascal Sonnet
NDNicola D'Amelio
Nicola D'Amelio
Despite the remarkable similarity in amino acid composition, many anticancer peptides (ACPs) display significant differences in terms of activity. This strongly suggests that particular relative dispositions of amino acids (motifs) play a role in the interaction with their biological target, which is often the cell membrane. To better verify this hypothesis, we intentionally modify HB43, an ACP active against a wide variety of cancers. Sequence alignment of related ACPs by ADAPTABLE web server highlighted the conserved motifs that could be at the origin of the activity. In this study, we show that changing the order of amino acids in such motifs results in a significant loss of activity against colon and breast cancer cell lines. On the contrary, amino acid substitution in key motifs may reinforce or weaken the activity, even when the alteration does not perturb the amphipathicity of the helix formed by HB43 on liposomes mimicking their surface. NMR and MD simulations with different membrane models (micelles, bicelles, and vesicles) indicate that the activity reflects the insertion capability in cancer-mimicking serine-exposing membranes, supported by the insertion of N-terminal phenylalanine in the FAK motif and the anchoring to the carboxylate of phosphatidylserine by means of arginine side chains.

29 July 1991 in FEBS Letters
Verified
Journal Article
Closed access
LMLaurent Martiny
Laurent Martiny
KDKarim Dib
Karim Dib
BHBernard Haye
Bernard Haye
CCClaude Corrèze
Claude Corrèze
CJClaude Jacquemin
Claude Jacquemin
BLBernard Lambert
Bernard Lambert

28 February 2001 in Cytokine
Verified
Journal Article
Closed access
CSChristophe Schneider
Christophe Schneider
NDN. Delorme
N. Delorme
HBH. El Btaouri
H. El Btaouri
WHW. Hornebeck
W. Hornebeck
BHB. Haye
B. Haye
LMLaurent Martiny
Laurent Martiny

1 September 2024 in American Journal of Physiology-Cell Physiology
Verified
Journal Article
Closed access
LVLaetitia Vanalderwiert
Laetitia Vanalderwiert
AHAuberi Henry
Auberi Henry
AWAmandine Wahart
Amandine Wahart
DBDaniel A. Carvajal Berrio
Daniel A. Carvajal Berrio
EBEva M. Brauchle
Eva M. Brauchle
Sébastien BlaiseSébastien Blaise
Sébastien Blaise
Aortic elastic fibers of young (6-mo old) individuals with diabetes degrade prematurely and exhibit an appearance like that found in aged (20-mo old) nondiabetic mice. Exacerbated elastolysis and elastin-derived peptide production are characteristic elements, contributing to early aortic wall rigidity and hypertension development. Therefore, limiting this early aging could be a judicious therapeutic approach to reduce cardiovascular complications and premature death in patients with diabetes.